版本:
中国

BRIEF-Edge Therapeutics says Albert Marchio II became CFO on an interim basis

March 13 Edge Therapeutics Inc

* Albert N. Marchio II, chief accounting and administrative officer, became Edge's CFO on an interim basis, effective March 10, 2017

* Andrew Einhorn, previously co's CFO, left co effective March 10, 2017 to pursue other interests - sec filing

* Edge Therapeutics Inc - Marchio will continue to serve as Edge's chief accounting and administrative officer - sec filing Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐